Efficacy and Survival Outcomes of Glofitamab in Central Nervous System Lymphoma: A Retrospective Study (ChiCTR) - Oct 16, 2026 - P=N/A | N=20 | Completed | Sponsor: Huashan Hospital, Fudan University; Huashan Hospital, Fudan University
New trial • CNS Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Primary Central Nervous System Lymphoma
|